Abstract
Androgenic alopecia (AGA) has a considerable impact on the physical and mental health of patients. Nano preparations have apparent advantages and high feasibility in the treatment of AGA. Cardamonin (CAR) has a wide range of pharmacological activities, but it has the problems of poor solubility in water and low bioavailability. There are few, if any, researches on the use of nano-loaded CAR to improve topical skin delivery of AGA. In this study, a CAR-loaded liposomal formulation (CAR@Lip and CAR@Lip Gel) was developed and characterized. The prepared CAR@Lip exhibited a uniform and rounded vesicle in size. CAR@Lip and CAR@Lip Gel can significantly improve the cumulative release of CAR. Additionally, CAR@Lip can obviously promote the proliferation and migration of human dermal papilla cells (hDPCs). Cell uptake revealed that the uptake of CAR@Lip significantly increased compared with the free drug. Furthermore, both CAR@Lip and CAR@Lip Gel groups could markedly improve the transdermal performance of CAR, and increase the topical content of the drug in the hair follicle compared with CAR. The ratchet effect of hair follicles could improve the skin penetration depth of nanoformulations. Notably, Anti-AGA tests in the mice showed that CAR@Lip and CAR@Lip Gel groups could promote hair growth, and accelerate the transition of hair follicles to the growth stage. The anti-androgen effect was revealed by regulating the expression of IGF-1, VEGF, KGF, and TGF-β, participating in SHH/Gli and Wnt/β-catenin pathways. Importantly, the nanoformulations had no obvious skin irritation. Thus, our study showed that CAR-loaded liposomal formulation has potential application in the treatment of AGA.
Graphical abstract
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available upon reasonable request.
References
Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149:15–24.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20:3759–81.
Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, Sansone A, Lombardo F. Androgenetic alopecia: a review. Endocrine. 2017;57:9–17.
Kwack MH, Sung YK, Chung EJ, Im SU, Ahn JS, Kim MK, Kim JC. Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. J Invest Dermatol. 2008;128:262–9.
Li Y, Yang S, Liao M, Zheng Z, Li M, Wei X, Liu M, Yang L. Association between genetically predicted leukocyte telomere length and non-scarring alopecia: a two-sample Mendelian randomization study. Front Immunol. 2013;13:1072573.
Yang M, Weng T, Zhang W, Zhang M, He X, Han C, Wang X. The Roles of non-coding RNA in the development and regeneration of hair follicles: Current status and further perspectives. Front Cell Dev Biol. 2021;9:720879.
Jain R, De-Eknamkul W. Potential targets in the discovery of new hair growth promoters for androgenic alopecia. Expert Opin Ther Targets. 2014;18:787–806.
Vasserot AP, Geyfman M, Poloso NJ. Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options. Expert Opin Ther Targets. 2019;23:755–71.
Hu XM, Li ZX, Zhang DY, Yang YC, Fu SA, Zhang ZQ, Yang RH, Xiong K. A systematic summary of survival and death signalling during the life of hair follicle stem cells. Stem Cell Res Ther. 2021;12:453.
Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198:89–95.
Cardoso CO, Tolentino S, Gratieri T, Cunha-Filho M, Lopez RFV, Gelfuso GM. Topical treatment for scarring and non-scarring alopecia: an overview of the current evidence. Clin Cosmet Investig Dermatol. 2021;14:485–99.
Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76:1349–64.
Buhl AE, Waldon DJ, Kawabe TT, Holland JM. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol. 1989;92:315–20.
Nawaz J, Rasul A, Shah MA, Hussain G, Riaz A, Sarfraz I, Zafar S, Adnan M, Khan AH, Selamoglu Z. Cardamonin: A new player to fight cancer via multiple cancer signaling pathways. Life Sci. 2020;250:117591.
Shrivastava S, Jeengar MK, Thummuri D, Koval A, Katanaev VL, Marepally S, Naidu VGM. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/beta-catenin signaling cascades and reversal of epithelial-mesenchymal transition. BioFactors. 2017;43:152–69.
Jia D, Tan Y, Liu H, Ooi S, Li L, Wright K, Bennett S, Addison CL, Wang L. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget. 2016;7:771–85.
Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, Li R, Niu M, Wang J, Liu Y, Xiao X, Bai Z. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin B. 2019;9:734–44.
Takahashi A, Yamamoto N, Murakami A. Cardamonin suppresses nitric oxide production via blocking the IFN-gamma/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice. Life Sci. 2011;89:337–42.
Yamamoto N, Kawabata K, Sawada K, Ueda M, Fukuda I, Kawasaki K, Murakami A, Ashida H. Cardamonin stimulates glucose uptake through translocation of glucose transporter-4 in L6 myotubes. Phytother Res. 2011;25:1218–24.
Wei D, Zhilun Y, Zhengtao W, Bei Y, Yijing R, Xiaoping L. Application of cardamonin to preparing medicine used for preventing and curing baldness. 2018. CN 108272781 A.
Lademann J, Knorr F, Richter H, Blume-Peytavi U, Vogt A, Antoniou C, Sterry W, Patzelt A. Hair follicles–an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charite - Universitatsmediz in Berlin, Germany. Skin Pharmacol Physiol. 2008;21:150–5.
Wilson V, Siram K, Rajendran S, Sankar V. Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit. Artif Cells Nanomed Biotechnol. 2018;46:1892–901.
Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv. 2012;9:783–804.
Lohani A, Verma A, Joshi H, Yadav N, Karki N. Nanotechnology-based cosmeceuticals. ISRN Dermatol. 2014;2014:843687.
Tripathi PK, Gorain B, Choudhury H, Srivastava A, Kesharwani P. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. Heliyon. 2019;5:e01343.
Lopedota A, Denora N, Laquintana V, Cutrignelli A, Lopalco A, Tricarico D, Maqoud F, Curci A, Mastrodonato M, la Forgia F, Fontana S, Franco M. Alginate-based hydrogel containing minoxidil/hydroxypropyl-beta-cyclodextrin inclusion complex for topical alopecia treatment. J Pharm Sci. 2018;107:1046–54.
Ke X, Wang C, Yan F. Filtration by microspore film for determination of the entrapment efficiency of Docetaxel liposomes. Chin J Mod Appl Pharm. 2008;25:314–5.
Guan Y, Han B, Tian Y, Jia Y, Sun Y. Preparation and quality evaluation of curcumin liposomes. J Chin Med Mater. 2019;42:385–9.
Abd E, Benson HAE, Roberts MS, Grice JE. Minoxidil skin delivery from nanoemulsion formulations containing eucalyptol or oleic acid: enhanced diffusivity and follicular targeting. Pharmaceutics. 2018;10:19.
Angelo T, El-Sayed N, Jurisic M, Koenneke A, Gelfuso GM, Cunha-Filho M, Taveira SF, Lemor R, Schneider M, Gratieri T. Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers. Sci Rep. 2020;10:176.
Menezes PD, Frank LA, Lima BD, de Carvalho YM, Serafini MR, Quintans-Junior LJ, Pohlmann AR, Guterres SS, Araujo AA. Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery. Int J Nanomedicine. 2017;12:2069–79.
Ruan X, Hu J, Lu L, Wang Y, Tang C, Liu F, Gao X, Zhang L, Wu H, Huang X, Wei Q. Poloxamer 407/188 Binary thermosensitive gel as a moxidectin delivery system: in vitro release and in vivo evaluation. Molecules. 2022;27:3063.
Wang WY, Cao YX, Zhou X, Wei B. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy. Drug Des Devel Ther. 2019;13:2205–13.
Kang M, Lee B, Leal C. Three-dimensional microphase separation and synergistic permeability in stacked lipid-polymer hybrid membranes. Chem Mater. 2017;29:9120–32.
Barbalata CI, Porfire AS, Casian T, Muntean D, Rus I, Tertis M, Cristea C, Pop A, Cherfan J, Loghin F, Tomuta I. The use of the QbD approach to optimize the co-loading of simvastatin and doxorubicin in liposomes for a synergistic anticancer effect. Pharmaceuticals (Basel). 2022;15:1211.
Zhang CX, Cheng Y, Liu DZ, Liu M, Cui H, Zhang BL, Mei QB, Zhou SY. Mitochondria-targeted cyclosporin. A delivery system to treat myocardial ischemia reperfusion injury of rats. J Nanobiotechnology. 2019;17:18.
Cho H, Kwon GS. Thermosensitive poly-(d, l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d, l-lactide-co-glycolide) hydrogels for multi-drug delivery. J Drug Target. 2014;22:669–77.
Zhao BX, Zhao Y, Huang Y, Luo LM, Song P, Wang X, Chen S, Yu KF, Zhang X, Zhang Q. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials. 2012;33:2508–20.
Keswani RK, Lazebnik M, Pack DW. Intracellular trafficking of hybrid gene delivery vectors. J Control Release. 2015;207:120–30.
Szymanowski F, Hugo AA, Alves P, Simoes PN, Gomez-Zavaglia A, Perez PF. Endocytosis and intracellular traffic of cholesterol-PDMAEMA liposome complexes in human epithelial-like cells. Colloids Surf B Biointerfaces. 2017;156:38–43.
Quan G, Pan X, Wang Z, Wu Q, Li G, Dian L, Chen B, Wu C. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J Nanobiotechnology. 2015;13:7.
Liu Q, Zhang J, Xia W, Gu H. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles. Nanoscale. 2012;4:3415–21.
Francia V, Reker-Smit C, Boel G, Salvati A. Limits and challenges in using transport inhibitors to characterize how nano-sized drug carriers enter cells. Nanomedicine (UK). 2019;14:1533–49.
Gao R, Yu Z, Lv C, Geng X, Ren Y, Ren J, Wang H, Ai F, Zhang B, Yue B, Wang Z, Dou W. Medicinal and edible plant Allium macrostemon Bunge for the treatment of testosterone-induced androgenetic alopecia in mice. J Ethnopharmacol. 2023;315:116657.
Fu H, Li W, Weng Z, Huang Z, Liu J, Mao Q, Ding B. Water extract of cacumen platycladi promotes hair growth through the Akt/GSK3beta/beta-catenin signaling pathway. Front Pharmacol. 2023;14:1038039.
Kim MJ, Seong KY, Kim DS, Jeong JS, Kim SY, Lee S, Yang SY, An BS. Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model. Acta Biomater. 2022;143:189–202.
Raber AS, Mittal A, Schafer J, Bakowsky U, Reichrath J, Vogt T, Schaefer UF, Hansen S, Lehr CM. Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm. J Control Release. 2014;179:25–32.
Manian M, Madrasi K, Chaturvedula A, Banga AK. Investigation of the dermal absorption and irritation potential of sertaconazole nitrate anhydrous gel. Pharmaceutics. 2016;8:21.
Yu H, He W, Guo X. Comparative study of liposomes and liposomes-in-hydrogel for transdermal absorption of Nimesulide. China Pharmacy. 2022;25:59–63.
Su R, Fan W, Yu Q, Dong X, Qi J, Zhu Q, Zhao W, Wu W, Chen Z, Li Y, Lu Y. Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization. Oncotarget. 2017;8:38214–26.
Shi T, Lv Y, Huang W, Fang Z, Qi J, Chen Z, Zhao W, Wu W, Lu Y. Enhanced transdermal delivery of curcumin nanosuspensions: A mechanistic study based on co-localization of particle and drug signals. Int J Pharm. 2020;588:119737.
Patzelt A, Lademann J. Recent advances in follicular drug delivery of nanoparticles. Expert Opin Drug Deliv. 2020;17:49–60.
Zhou H, Luo D, Chen D, Tan X, Bai X, Liu Z, Yang X, Liu W. Current advances of nanocarrier technology-based active cosmetic ingredients for beauty applications. Clin Cosmet Investig Dermatol. 2021;14:867–87.
Shen YL, Li XQ, Pan RR, Yue W, Zhang LJ, Zhang H. Medicinal plants for the treatment of hair loss and the suggested mechanisms. Curr Pharm Des. 2018;24:3090–100.
Junlatat J, Sripanidkulchai B. Hair growth-promoting effect of Carthamus tinctorius floret extract. Phytother Res. 2014;28:1030–6.
Bak SS, Ahn BN, Kim JA, Shin SH, Kim JC, Kim MK, Sung YK, Kim SK. Ecklonia cava promotes hair growth. Clin Exp Dermatol. 2013;38:904–10.
Chung MS, Bae WJ, Choi SW, Lee KW, Jeong HC, Bashraheel F, Jeon SH, Jung JW, Yoon BI, Kwon EB, Oh HA, Hwang SY, Kim SW. An asian traditional herbal complex containing Houttuynia cordata Thunb, Perilla frutescens Var. acuta and green tea stimulates hair growth in mice. BMC Complement Altern Med. 2017;17:515.
Fu J, Hsu W. Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis. J Invest Dermatol. 2013;133:890–8.
Wang X, Liu Y, He J, Wang J, Chen X, Yang R. Regulation of signaling pathways in hair follicle stem cells. Burns Trauma. 2022;10:tkac022.
Zheng L, Rui C, Zhang H, Chen J, Jia X, Xiao Y. Sonic hedgehog signaling in epithelial tissue development. Regen Med Res. 2019;7:3.
Lu GQ, Wu ZB, Chu XY, Bi ZG, Fan WX. An investigation of crosstalk between Wnt/beta-catenin and transforming growth factor-beta signaling in androgenetic alopecia. Medicine. 2016;95:e4297.
Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–99.
Weiying G, Di W. Relationship of solubility characteristics of ginsenoside and LBP with liposome entrapment efficiency. China Pharmacy. 2011;22:3300–2.
Bhowmick M, Sengodan T. Mechanisms, kinetics and mathematical modelling of transdermal permeation- an updated review. Int J Res Dev Pharm Life Sci. 2013;06:1–4.
Gu Y, Bian Q, Zhou Y, Huang Q, Gao J. Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders, Asian. J Pharm Sci. 2022;17:333–52.
Su YS, Fan ZX, Xiao SE, Lin BJ, Miao Y, Hu ZQ, Liu H. Icariin promotes mouse hair follicle growth by increasing insulin-like growth factor 1 expression in dermal papillary cells. Clin Exp Dermatol. 2017;42:287–94.
Lee EY, Choi EJ, Kim JA, Hwang YL, Kim CD, Lee MH, Roh SS, Kim YH, Han I, Kang S. Malva verticillata seed extracts upregulate the Wnt pathway in human dermal papilla cells. Int J Cosmet Sci. 2016;38:148–54.
Park S, Shin WS, Ho J. Fructus panax ginseng extract promotes hair regeneration in C57BL/6 mice. J Ethnopharmacol. 2011;138:340–4.
Lee H, Kim NH, Yang H, Bae SK, Heo Y, Choudhary I, Kwon YC, Byun JK, Yim HJ, Noh BS, Heo JD, Kim E, Kang C. The hair growth-promoting effect of rumex japonicus houtt. extract. Evid Based Complement Alternat Med. 2016;2016:1873746.
Shin SH, Bak SS, Kim MK, Sung YK, Kim JC. Baicalin, a flavonoid, affects the activity of human dermal papilla cells and promotes anagen induction in mice. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:583–6.
Sakaguchi I, Ishimoto H, Matsuo M, Ikeda N, Minamino M, Kato Y. The water-soluble extract of Illicium anisatum stimulates mouse vibrissae follicles in organ culture. Exp Dermatol. 2004;13:499–504.
Jeong GH, Boisvert WA, Xi MZ, Zhang YL, Choi YB, Cho S, Lee S, Choi C, Lee BH. Effect of miscanthus sinensis var. purpurascens flower extract on proliferation and molecular regulation in human dermal papilla cells and stressed C57BL/6 Mice. Chin J Integr Med. 2018;24:591–9.
Yang Y, Wang P, Gong Y, Yu Z, Gan Y, Li P, Liu W, Wang X. Curcumin-zinc framework encapsulated microneedle patch for promoting hair growth. Theranostics. 2023;13:3675–88.
Acknowledgements
We thank prof. Wei Wu from the School of Pharmacy, Fudan University, for providing P4 fluorescence probe.
Funding
This work was sponsored by Program for Shanghai High-Level Local University Innovation Team [SZY20220315].
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design of this manuscript. The original draft of the manuscript, investigation, and formal analysis were performed by Zhenda Liu. The data was collected, processed, interpreted, and drafted by Zehui He and Xinyi Ai. Teng Guo wrote, reviewed, and edited the study. Nianping Feng supervised the study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethical statement
The study was reviewed and approved by the Experimental Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine with registration numbers PZSHUTCM210723001 and PZSHUTCM210926005.
Consent for publication
All the authors approve the publication.
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, Z., He, Z., Ai, X. et al. Cardamonin-loaded liposomal formulation for improving percutaneous penetration and follicular delivery for androgenetic alopecia. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01519-8
Accepted:
Published:
DOI: https://doi.org/10.1007/s13346-024-01519-8